PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy. Electronic address: luca.quartuccio@asufc.sanita.fvg.it.\', \'Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy.\', \'National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC), Leeds Teaching Hospitals, Leeds, UK.\', \'Institute of Clinical Pathology, ASUFC, Udine, Italy.\', \'Infectious Diseases Unit, ASUFC, Udine, Italy.\', \'Department of Anesthesia and Intensive Care, ASUFC, Udine, Italy; Department of Medicine, Anesthesia and Intensive Care Clinic, University of Udine, Udine, Italy.\', \'Department of Anesthesia and Intensive Care, ASUFC, Udine, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1386-6532(20)30186-410.1016/j.jcv.2020.104444
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
is ?:pmid of
?:pmid
?:pmid
  • 32570043
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all